ETFs to Play the Reopening Trade on Merck's Oral Antiviral Pill News

[unable to retrieve full-text content]An emergency use authorization from the FDA would make molnupiravir the first oral antiviral to combat COVID-19. Despite being spooked about inflation and price pressure, investors played the …